Other, net - Additional Information (Detail) - USD ($) $ in Thousands |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2015 |
Dec. 31, 2014 |
Dec. 31, 2013 |
|
Other Income Expense [Line Items] | |||
Realized gain on available-for-sale securities | $ 24,465 | ||
Deferred tax assets, valuation allowance | $ 8,700 | ||
Yodlee, Inc. [Member] | |||
Other Income Expense [Line Items] | |||
Cost basis investment | 9,800 | ||
Additional investment | $ 1,000 | ||
Total investments | $ 10,800 | ||
Realized gain on available-for-sale securities | $ 24,500 | 23,000 | |
Cost basis price appreciation of shares | $ 10,800 |
X | ||||||||||
- Definition Amount of additional investment made in a cost-method investment after original acquisition date. No definition available.
|
X | ||||||||||
- Definition Other Income Expense [Line Items] No definition available.
|
X | ||||||||||
- Definition This item represents the cost of equity securities, which are categorized neither as held-to-maturity nor trading, net of adjustments for other-than-temporary impairments recognized in earnings (less any cumulative-effect adjustments recognized, as defined), and fair value hedge accounting adjustments, if any. No definition available.
|
X | ||||||||||
- Definition This item represents the difference between the gross realized gains and losses realized on the sale of debt or equity securities categorized neither as held-to-maturity nor trading securities. Additionally, this item would include any losses recognized for other than temporary impairments (OTTI) of the subject investments in debt and equity securities. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition This element represents the aggregate carrying amount of all cost-method investments held by the Entity which was not evaluated for impairment. Because the fair value of cost-method investments is not readily determinable, the evaluation of whether an investment is impaired generally consists of whether an event or change in circumstances has occurred during the reporting period that may have a significant adverse effect on the fair value of the investment (an "impairment indicator"). Impairment indicators include, but are not limited to: (1) significant deterioration in the earnings performance, credit rating, asset quality, or business prospects of the investee; (2) significant adverse change in the regulatory, economic, or technological environment of the investee; (3) significant adverse change in the general market condition of either the geographic area or the industry in which the investee operates; (4) a bona fide offer to purchase (whether solicited or unsolicited), an offer by the investee to sell, or a completed auction process for the same or similar security for an amount less than the cost of the investment; or (5) factors that raise significant concerns about the investee's ability to continue as a going concern, such as negative cash flows from operations, working capital deficiencies, or noncompliance with statutory capital requirements or debt covenants. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Original amount of cost-method investments at the acquisition date. No definition available.
|
X | ||||||||||
- Definition Amount of valuation allowance of deferred tax asset attributable to deductible temporary differences and carryforwards, classified as noncurrent. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Details
|